Related references
Note: Only part of the references are listed.Epidemiology of Invasive Fungal Infections in Latin America
Jose Sifuentes-Osornio et al.
CURRENT FUNGAL INFECTION REPORTS (2012)
Epidemiology, Species Distribution, Antifungal Susceptibility and Outcome of Nosocomial Candidemia in a Tertiary Care Hospital in Italy
Matteo Bassetti et al.
PLOS ONE (2011)
Design and synthesis of new adamantyl-substituted antileishmanial ether phospholipids
Ioannis Papanastasiou et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Epidemiology of Opportunistic Fungal Infections in Latin America
Marcio Nucci et al.
CLINICAL INFECTIOUS DISEASES (2010)
Alterations in the homeostasis of phospholipids and cholesterol by antitumor alkylphospholipids
Jose M. Jimenez-Lopez et al.
LIPIDS IN HEALTH AND DISEASE (2010)
Trailing end-point phenotype antibiotic-sensitive strains of Candida albicans produce different amounts of aspartyl peptidases
L. A. Braga-Silva et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2009)
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2009)
Thymol inhibits Candida albicans biofilm formation and mature biofilm
Pier Carlo Braga et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Design and synthesis of potent antileishmanial cycloalkylidene-substituted ether phospholipid derivatives
Theodora Calogeropoulou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Synthesis, antifungal and antimicrobial activity of alkylphospholipids
Daniel Obando et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
3D-Quantitative structure-activity relationships of synthetic antileishmanial ring-substituted ether phospholipids
Agnes Kapou et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia
Mario Tumbarello et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Mechanisms of action of lysophospholipid analogues against trypanosomatid parasites
Julio A. Urbina
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2006)
Hexadecylphosphocholine (Miltefosine) has broad-spectrum fungicidal activity and is efficacious in a mouse model of cryptococcosis
F Widmer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Modification of surface properties of biomaterials influences the ability of Candida albicans to form biofilms
J Chandra et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2005)
Chemotherapy of trypanosomiases and leishmaniasis
SL Croft et al.
TRENDS IN PARASITOLOGY (2005)
Determination of fungicidal activities against yeasts and molds: Lessons learned from bactericidal testing and the need for standardization
MA Pfaller et al.
CLINICAL MICROBIOLOGY REVIEWS (2004)
Candida biofilm resistance
PK Mukherjee et al.
DRUG RESISTANCE UPDATES (2004)
Mechanism of fluconazole resistance in Candida albicans biofilms:: Phase-specific role of efflux pumps and membrane sterols
PK Mukherjee et al.
INFECTION AND IMMUNITY (2003)
Biofilm-forming a ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection
Y Jin et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Antileishmanial ring-substituted ether phospholipids
N Avlonitis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Antiprotozoal activities of phospholipid analogues
SL Croft et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2003)
Choline transport in Leishmania major promastigotes and its inhibition by choline and phosphocholine analogs
R Zufferey et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2002)
Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms
G Ramage et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Antifungal susceptibility of Candida biofilms:: Unique efficacy of amphotericin B lipid formulations and echinocandins
DM Kuhn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Biofilms: Survival mechanisms of clinically relevant microorganisms
RM Donlan et al.
CLINICAL MICROBIOLOGY REVIEWS (2002)
Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms
G Ramage et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Biofilm formation by the fungal pathogen Candida albicans:: Development, architecture, and drug resistance
J Chandra et al.
JOURNAL OF BACTERIOLOGY (2001)
Guidelines for the management of intravascular catheter-related infections
LA Mermel et al.
CLINICAL INFECTIOUS DISEASES (2001)
Share Paper
